2nd Edition of Pharma R&D and Drug Discovery World Conference 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2nd Edition of Pharma R&D and Drug Discovery World Conference 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
2nd Edition of Pharma R&D and Drug Discovery World Conference 2026
The Pharma R&D and Drug Discovery World Conference (PRDWC) 2026 is a premier global gathering of scientists, researchers, and industry experts dedicated to advancing pharmaceutical innovation and drug discovery. This hybrid event (in-person and virtual) will take place from October 16-18, 2026 at the Ambassador Hotel in Bangkok, Thailand, offering unparalleled opportunities for collaboration, knowledge exchange, and insight into cutting-edge research.
Event Overview
Building on the success of the 2025 edition, PRDWC 2026 will address critical challenges and breakthroughs in pharmaceutical research and development. The conference will feature sessions on:
- Personalized medicine
- Drug delivery systems
- Nanomedicine
- Pharmacogenomics
- Advancements in drug discovery technology
Why Attend?
PRDWC 2026 provides a unique platform for:
- Networking with thought leaders across academia, industry, and regulatory bodies
- Access to trending research studies and emerging technologies
- Opportunities for collaboration and business development
- Professional growth through accredited sessions and workshops
Target Audience
The event attracts a diverse global audience, including:
- Pharmaceutical and biotechnology researchers
- Clinical development specialists
- Academic scientists and professors
- Industry executives and decision-makers
- Government and regulatory affairs professionals
- Investors and venture capitalists in healthcare innovation
Key Highlights
- 100+ speakers and 500+ attendees from 30+ countries
- Exhibition of cutting-edge technologies and services
- Abstract submissions and poster presentations
- Early bird registration and abstract deadlines: 25 June 2026 (Abstracts), 30 June 2026 (Registration)
Event Details
Venue: Ambassador Hotel, Bangkok, Thailand
Contact: +1-571-5561014 | pharmarnd@precisionglobalconferences.com
Hybrid Participation: Attend in-person or virtually via digital platforms.
Call to Action
Register Now | Submit Abstract | Download Brochure
Organized by Precision Global Conferences (PGC) – Empowering innovation through global scientific collaboration.
Data sheet
2nd Edition of Pharma R&D and Drug Discovery World Conference 2026 – Event Attendee & Buyer Profile Analysis
Event date: October 16–18, 2026
Location: Ambassador Hotel Bangkok, Bangkok, Thailand
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 2nd Edition of Pharma R&D and Drug Discovery World Conference 2026 |
| Event Date | October 16–18, 2026 |
| Event Status | Upcoming |
| Venue | Ambassador Hotel Bangkok |
| City | Bangkok |
| State / Region | Bangkok Metropolitan Region |
| Country | Thailand |
| Organizer | Precision Global Conferences (PGC) |
| Official Event Website | pharmadrugresearchconference.com |
| Event Type | Hybrid scientific conference and networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology |
| Audience Reach | Global, supported by hybrid in-person and virtual participation |
| Estimated Attendance / Expected Footfall | 100+ visitors stated on official website |
| Attendance Data Reliability | Confirmed website claim for “100+ Visitors”; broader attendee composition and buyer counts not publicly confirmed by the organizer |
| Main Purpose of Event | To convene scientists, researchers, and pharma industry experts around drug discovery, pharmaceutical R&D, clinical development, biotechnology, pharmacology, and innovative therapeutics. |
About the Event
The 2nd Edition of Pharma R&D and Drug Discovery World Conference 2026 is an upcoming hybrid conference focused on pharmaceutical innovation, research, and drug development. According to the official event website, the conference will take place October 16–18, 2026 at Ambassador Hotel Bangkok, Thailand, with virtual participation also available. Published program themes include personalized medicine, drug delivery systems, nanomedicine, pharmacogenomics, and advancements in drug discovery technology.
From a commercial and attendee-intelligence perspective, this event appears most relevant for scientific networking, partnership development, early-stage solution visibility, research collaboration, and BD outreach into pharmaceutical R&D ecosystems. The official website positions the conference as a global forum for scientists, researchers, and industry experts, making it more suitable for targeted account-based outreach and speaker/sponsor intelligence than for mass-volume trade show list building.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Pharmaceutical R&D leaders | Pharma companies, specialty therapeutics firms, global drug developers | Influence platform evaluation, discovery partnerships, outsourced research, and innovation sourcing | High relevance for CROs, discovery technology vendors, data platforms, and lab solution providers |
| Drug discovery scientists | Discovery biology teams, medicinal chemistry groups, translational research units | Technical evaluators and end users of platforms, assays, compounds, and workflow tools | Important for technical adoption, pilot programs, and product validation conversations |
| Clinical development and translational medicine teams | Biopharma clinical organizations, translational medicine groups | Assess late-discovery to development handoff, biomarker strategy, and clinical readiness tools | Relevant for CROs, biomarker vendors, clinical data providers, and regulatory advisory firms |
| Biotechnology company executives | Emerging biotech, therapeutic startups, platform companies | Budget holders for collaborations, licensing, research services, and specialist tools | Strong fit for partnership-led outreach and solution co-development |
| Academic and research institution scientists | Universities, biomedical institutes, translational research centers | Influence equipment, software, grants collaboration, and publication-related tool adoption | Relevant for lab vendors, scientific software, imaging, and research services |
| Regulatory and pharmacology experts | Regulatory advisory groups, pharmacology units, compliance specialists | Provide gatekeeping influence on development pathways and compliance readiness | Useful for regulatory services, documentation tools, and risk-management solutions |
| Innovation, partnerships, and business development teams | Biopharma BD groups, strategic alliance teams, licensing teams | Source technologies, partnerships, licensing opportunities, and external innovation pipelines | High-value targets for deal sourcing, service partnerships, and strategic introductions |
| Technology and data platform stakeholders | Bioinformatics teams, AI drug discovery groups, scientific software users | Influence procurement of analytics, automation, cloud research platforms, and modeling tools | Relevant for software, AI, informatics, and workflow automation suppliers |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Bangkok | Local scientific, healthcare, research, and life sciences professionals | Moderate | Host city for the in-person conference component |
| Thailand | National attendees from pharma, biotech, universities, hospitals, and research institutes | Moderate | Likely domestic draw due to location and accessibility |
| Southeast Asia | Regional academics, biotech firms, pharma affiliates, and CRO stakeholders | High | Bangkok is a strong regional meeting hub for ASEAN business travel |
| Asia-Pacific | Cross-border R&D, biotech, and scientific attendees | High | Hybrid format expands reach beyond physical attendance |
| Europe and North America | Global researchers, speakers, and virtual participants | Selective | Official website describes the event as global and hybrid |
| Virtual participation base | International remote attendees | Variable | Officially promoted as a hybrid event; supports global audience extension |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website explicitly positions the conference as a global gathering and offers both in-person Bangkok attendance and virtual participation. |
| Regional | Secondary practical reach | The in-person component is likely to be strongest across Thailand and broader Asia-Pacific life sciences markets. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Current-year buyer / attendee organizations not publicly disclosed | N/A | The official event website reviewed does not publish a 2026 attendee directory, confirmed buyer list, exhibitor roster, sponsor list, or speaker-organization list sufficient to verify individual buyer companies. | N/A | R&D Director; Head of Drug Discovery; Scientific Affairs Director; Translational Medicine Lead; BD Director | Confirmed limitation |
This event is suitable for targeted B2B attendee profiling at the segment level, but not currently suitable for confirmed current-year buyer-company list extraction based on the public materials reviewed. Additional official speaker, sponsor, exhibitor, or participant directories would materially improve account-level targeting.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Head of Drug Discovery | R&D | Director / VP / Head | Core decision-maker for discovery platforms, collaboration models, and scientific partnerships |
| 2 | R&D Director | Research & Development | Director | Influences research budgets, vendor reviews, and project adoption |
| 3 | VP Research | Executive / R&D | VP | Senior authority for platform selection, therapeutic priorities, and alliance strategy |
| 4 | Principal Scientist | Discovery Science | Manager / Director / Individual Contributor | Often evaluates technical fit and influences proof-of-concept adoption |
| 5 | Translational Medicine Lead | Clinical / Translational | Director / Senior Manager | Relevant where offerings support biomarker strategy, preclinical-to-clinical transition, or patient stratification |
| 6 | Scientific Affairs Director | Scientific Affairs | Director | Important for educational partnerships, thought leadership, and scientific validation |
| 7 | Business Development Director | Business Development / Partnerships | Director | Useful for licensing, co-development, and service partnership discussions |
| 8 | Partnerships Director | Strategic Alliances | Director | Relevant for external innovation and collaborative deal flow |
| 9 | Bioinformatics Director | Data Science / Informatics | Director | High-fit for AI, analytics, computational biology, and data infrastructure suppliers |
| 10 | Lab Operations Manager | Laboratory Operations | Manager | Key operational user for equipment, workflow tools, and lab productivity solutions |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Direct match to drug discovery and pharma R&D agenda | Therapeutics development, discovery workflows, external research partnerships |
| 2 | Biotechnology | Strong overlap with innovative therapeutics and platform science | Platform licensing, assay solutions, translational partnerships |
| 3 | Research | Relevant for scientific institutes and contract research environments | Academic collaboration, lab technologies, data tools |
| 4 | Hospital & Health Care | Relevant where translational medicine, clinical research, and therapeutics evaluation intersect | Clinical collaboration and applied research support |
| 5 | Medical Devices | Relevant for drug delivery systems and enabling technologies | Delivery platforms, monitoring solutions, interface technologies |
| 6 | Information Technology & Services | Supports scientific data, cloud workflows, and digital research operations | Scientific software, data integration, cloud enablement |
| 7 | Computer Software | Applicable to modeling, analytics, AI, and research informatics | Drug discovery software, cheminformatics, LIMS-related tools |
| 8 | Higher Education | Academic researchers are a core participant group for scientific conferences | Research collaboration, instrument adoption, grants-linked projects |
| 9 | Nanotechnology | Official agenda mentions nanomedicine | Nano-enabled therapeutics and formulation partnerships |
| 10 | Health, Wellness & Fitness | Secondary relevance for personalized medicine and health innovation ecosystems | Innovation-adjacent outreach where precision health overlaps with therapeutics |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 100+ visitors | Confirmed | Official event website | Stated as “100+ Visitors” on the official website |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No public roster reviewed | Sponsors/Exhibitors navigation exists, but no verified count was available in the provided source text |
| Buyer count | Attendance figure not publicly confirmed by the organizer | Unconfirmed | No buyer list published in reviewed material | No dedicated hosted buyer or procurement program identified |
| Speaker count | Not publicly confirmed in reviewed text | Unconfirmed | Speaker menu present but no count extracted from provided source text | Would require direct review of speaker pages or brochure |
| Sponsor count | Not publicly confirmed in reviewed text | Unconfirmed | No sponsor roster captured in provided source text | Commercial partnership scope not measurable from available material |
| Historical attendance | Prior-year participation mentioned qualitatively | Historical / prior-year evidence | Official website references PRDWC 2025 success | No numeric 2025 attendance figure confirmed in the provided material |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Drug discovery | Faster target identification, screening efficiency, and scientific differentiation | Technical demos, pilot projects, co-development, scientific validation | Discovery platforms, assays, screening technologies, informatics |
| Pharmaceutical R&D | Improved research productivity, portfolio advancement, and external innovation access | Executive meetings, partnership outreach, solution benchmarking | CRO services, research platforms, collaboration services |
| Personalized medicine | Patient stratification, precision targeting, translational insights | Cross-functional scientific and clinical discussions | Biomarker tools, analytics, companion technology support |
| Drug delivery systems | Formulation, delivery optimization, device-interface improvement | Solution showcases and technical collaboration discussions | Delivery devices, formulation services, materials innovation |
| Nanomedicine | Advanced formulation and targeted therapeutic innovation | Scientific networking and specialist vendor discussions | Nanotech platforms, research materials, formulation expertise |
| Pharmacogenomics | Genomics integration into therapeutic development | Research collaboration and data-platform evaluation | Genomic analysis tools, data infrastructure, bioinformatics |
| Innovation and partnerships | Access to external capabilities, novel platforms, and strategic collaborators | BD meetings, alliance discussions, licensing conversations | Partnership sourcing, scientific services, platform alliances |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The theme is tightly aligned with pharmaceutical R&D, discovery science, and scientific partnerships. |
| Decision-maker availability | Medium | Likely presence of senior scientific leaders, but public confirmation of named decision-makers was limited in reviewed materials. |
| Data collection potential | Medium | Good for segment-level profiling; weaker for verified account-level list building without additional official directories. |
| Apollo targeting potential | High | The event maps clearly to pharmaceutical, biotech, research, and scientific-software audiences in Apollo. |
| Geographic targeting potential | High | Bangkok plus regional APAC and hybrid global participation makes geography-based filtering practical. |
| Best outreach approach | High-touch ABM | Best results likely from scientific relevance messaging, partnership framing, and targeted role-based outreach. |
| Overall lead quality | High | Quality is likely strong for niche life sciences solutions, though volume appears limited relative to major trade exhibitions. |
| Best use case | Targeted life sciences prospecting | Useful for speaker outreach, sponsor targeting, partnership introductions, and account-based life sciences campaigns. |
| Limitations / risks | Medium | Publicly available account-level attendee proof is limited; event appears conference-led rather than large expo-led. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Research; Hospital & Health Care; Medical Devices; Information Technology & Services; Computer Software; Higher Education; Nanotechnology | Build a focused universe aligned to the conference themes and likely attendee base |
| Departments | Research; Engineering; Information Technology; Business Development; Operations; Education | Capture both scientific and commercial stakeholders |
| Seniority | CXO; VP; Director; Head; Manager; Partner | Prioritize budget holders and technical influencers |
| Job titles | Head of Drug Discovery; R&D Director; VP Research; Principal Scientist; Translational Medicine Lead; Scientific Affairs Director; Business Development Director; Partnerships Director; Bioinformatics Director; Lab Operations Manager | Mirror the highest-likelihood attendee profiles |
| Geography | Thailand; Singapore; Malaysia; Indonesia; Vietnam; Philippines; South Korea; Japan; India; Australia; United States; United Kingdom; Germany; Switzerland | Match Bangkok regional draw plus likely global virtual participation |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Covers emerging biotech through large pharmaceutical enterprises |
| Keywords | drug discovery, pharmaceutical R&D, translational medicine, pharmacogenomics, nanomedicine, drug delivery, therapeutics, preclinical, discovery platform, medicinal chemistry, bioinformatics, precision medicine | Improve event-theme relevance inside broad industry filters |
| Technologies, if relevant | LIMS, bioinformatics platforms, cloud research tools, AI/ML analytics, genomics software | Useful for vendors selling scientific software or discovery-enabling infrastructure |
| Revenue range, if relevant | $1M–$50M for emerging biotech; $50M–$1B+ for established biopharma | Separate innovation-stage firms from scaled enterprise buyers |
| Company type | Private; Public; Nonprofit; Academic / Research Institution | Captures commercial, institutional, and scientific ecosystems around the event |
Suggested Apollo Search Logic: ("drug discovery" OR "pharmaceutical R&D" OR pharmacogenomics OR nanomedicine OR "drug delivery" OR "translational medicine" OR therapeutics OR preclinical OR bioinformatics) AND (Director OR VP OR Head OR Manager) AND industry in [Pharmaceuticals, Biotechnology, Research, Medical Devices, Hospital & Health Care, Computer Software, Information Technology & Services].
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Pharma R&D & Drug Discovery Conference (PRDWC) 2026 Official Website | Official event website | Event title, hybrid format, dates, venue, Bangkok location, Thailand country, thematic focus, organizer contact context, and “100+ Visitors” website claim | High |
| Official website navigation and event copy reviewed in provided source text | Official organizer-published page content | Confirmed that public attendee/company-level rosters were not available in the reviewed source text; no verified current-year buyer list identified | High for limitations noted |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2nd Edition of Pharma R&D and Drug Discovery World Conference 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds